Parental Education on Passive Smoke Exposure and Respiratory Diseases in Infants
Recruitment status was Not yet recruiting
Parental smoking is associated with increased frequency of respiratory diseases including hospitalizations in infants.
Study hypothesis: Parental education regarding the association between parental smoking and respiratory diseases in the infant, and guidance on ways to decrease smoke exposure by the infant, provided shortly after the infant is born, will decrease infants' morbidity.
|Study Design:||Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention
- The number of episodes of cough/wheeze/asthma/bronchitis during the first 3 months and 1 year. [ Time Frame: 3 months and 1 year ] [ Designated as safety issue: No ]
- The number of ED visits and hospitalizations for respiratory diseases in the first 3 months and 1 year [ Time Frame: 3 months and 1 year ] [ Designated as safety issue: No ]
|Study Start Date:||October 2008|
|Estimated Study Completion Date:||October 2009|
|Estimated Primary Completion Date:||November 2008 (Final data collection date for primary outcome measure)|
|No Intervention: non-smoking|
|No Intervention: smoking parents A|
Experimental: smoking parents B
Parents will be educated on the hazards of passive smoke exposure and ways to reduce it
Smoking parents will receive education on the association between parental smoking and respiratory morbidity in the infant. They will also be offered ways to reduce smoke exposure of their infants.
Mothers who are in Maternity ward following birth will fill a questionnaire regarding smoking habits. Parents will be divided into non-smokers and smokers. Half of the smoking mothers will receive guidance regarding the association between parents smoking and respiratory diseases in the infant. They will also get ideas on how to reduce smoke exposure by their infant. 3 months and 1 year later all parents will be contacted by phone and asked about their children's health.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00757224
|Contact: Arnon Elizur, MDemail@example.com|
|Asaf Harofeh Medical Center||Not yet recruiting|
|Zerifin, Israel, 70300|
|Contact: Arnon Elizur, MD 972-8-9779817 firstname.lastname@example.org|